|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
CA2711558C
(en)
|
2008-01-04 |
2016-12-13 |
Intellikine, Inc. |
Phosphatidyl inositol-3 kinase inhibiting compounds
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
EP2845856A1
(en)
|
2009-06-29 |
2015-03-11 |
Incyte Corporation |
Pyrimidinones as PI3K inhibitors
|
|
EP2525790B1
(en)
|
2009-10-21 |
2020-05-27 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
EP3064595B1
(en)
|
2009-10-21 |
2019-02-27 |
Agios Pharmaceuticals, Inc. |
Methods for cell-proliferation-related disorders
|
|
WO2011075630A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
|
|
US8759359B2
(en)
*
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
|
US9403769B2
(en)
|
2010-02-22 |
2016-08-02 |
Advanced Cancer Therapeutics, Llc |
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
CN105130948A
(zh)
|
2010-04-22 |
2015-12-09 |
弗特克斯药品有限公司 |
制备环烷基甲酰胺基-吲哚化合物的方法
|
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
|
WO2011161201A1
(en)
|
2010-06-22 |
2011-12-29 |
Kancera Ab |
Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer
|
|
US9233946B2
(en)
|
2010-09-17 |
2016-01-12 |
Kancera Ab |
Sulfonamide compounds
|
|
TW201249844A
(en)
|
2010-12-20 |
2012-12-16 |
Incyte Corp |
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
|
|
AU2012205669B2
(en)
|
2011-01-10 |
2015-08-20 |
Infinity Pharmaceuticals Inc. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
|
GB201103762D0
(en)
|
2011-03-07 |
2011-04-20 |
Vib Vzw |
Means and methods for the treatment of neurodegenerative disorders
|
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
US9492418B2
(en)
|
2011-05-10 |
2016-11-15 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Inhibitors of PFKFB3 for cancer therapy
|
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
|
GB201112145D0
(en)
|
2011-07-15 |
2011-08-31 |
Vib Vzw |
Means and methods for the treatment of pathological angiogenesis
|
|
UA121539C2
(uk)
|
2011-09-02 |
2020-06-25 |
Інсайт Холдинґс Корпорейшн |
Гетероцикліламіни як інгібітори рі3к
|
|
US10000449B2
(en)
|
2011-12-22 |
2018-06-19 |
Kancera Ab |
Bisarylsulfonamides useful in the treatment of inflammation and cancer
|
|
CN104168958B
(zh)
|
2011-12-22 |
2017-12-01 |
坎塞拉有限公司 |
可用于治疗炎症和癌症的二芳基磺酰胺
|
|
EP2831047B1
(en)
*
|
2012-03-29 |
2017-05-03 |
Advanced Cancer Therapeutics, LLC |
Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
KR102229478B1
(ko)
|
2012-11-01 |
2021-03-18 |
인피니티 파마슈티칼스, 인코포레이티드 |
Pi3 키나아제 동형단백질 조절인자를 사용하는 암의 치료
|
|
US8871754B2
(en)
|
2012-11-19 |
2014-10-28 |
Irm Llc |
Compounds and compositions for the treatment of parasitic diseases
|
|
SI2925757T1
(en)
|
2012-11-19 |
2018-01-31 |
Novartis Ag |
Compounds and compositions for the treatment of parasitic diseases
|
|
US9663486B2
(en)
|
2013-10-14 |
2017-05-30 |
Eisai R&D Management Co., Ltd. |
Selectively substituted quinoline compounds
|
|
TWI624467B
(zh)
|
2013-10-14 |
2018-05-21 |
衛材Ｒ＆Ｄ企管股份有限公司 |
選擇性經取代之喹啉化合物
|
|
JP6543268B2
(ja)
|
2014-04-15 |
2019-07-10 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
嚢胞性線維症膜コンダクタンス調節因子が媒介する疾患を処置するための医薬組成物
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
GB201407693D0
(en)
*
|
2014-05-01 |
2014-06-18 |
Univ Montfort |
Compound
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
UA122332C2
(uk)
|
2015-02-27 |
2020-10-26 |
Інсайт Корпорейшн |
Солі інгібітора pi3k і способи їх отримання
|
|
WO2016172499A1
(en)
*
|
2015-04-24 |
2016-10-27 |
University Of Louisville Research Foundation, Inc. |
Selective pfkfb4 inhibitors for the treatment of cancer
|
|
WO2016183063A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Crystalline forms of a pi3k inhibitor
|
|
WO2016183060A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
US20180118718A1
(en)
*
|
2015-05-13 |
2018-05-03 |
Selvita S.A. |
Substituted Quinoxaline Derivatives
|
|
US20180147198A1
(en)
*
|
2015-05-28 |
2018-05-31 |
University Of Louisville Research Foundation, Inc. |
Combinations of pfkfb3 inhibitors and immune checkpoint inhibitors to treat cancer
|
|
WO2017208174A2
(en)
*
|
2016-05-31 |
2017-12-07 |
The Regents Of The University Of California |
Methods of treating disease with pfkfb3 inhibitors
|
|
MX391135B
(es)
|
2016-06-24 |
2025-03-21 |
Infinity Pharmaceuticals Inc |
Terapias de combinacion.
|
|
CA3069720A1
(en)
|
2017-07-11 |
2019-01-17 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US10774046B2
(en)
|
2017-10-26 |
2020-09-15 |
University Of Louisville Research Foundation, Inc. |
Inhibitors for the treatment of cancer and related methods
|
|
MX2020012826A
(es)
|
2018-06-01 |
2021-03-09 |
Incyte Corp |
Regimen de dosificacion para el tratamiento de trastornos relacionados con fosfatidilinositol 3-cinasas (pi3k).
|
|
WO2020030613A1
(en)
|
2018-08-07 |
2020-02-13 |
Kemijski Institut |
Small molecule-inhibitors of 6-phosphofructo-1-kinase for reducing lactate generation by cancer cells
|
|
CN109535068B
(zh)
*
|
2018-12-26 |
2022-07-29 |
中国药科大学 |
吡啶取代查尔酮类化合物或其可药用的盐及其制备方法和用途
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
MX2022006865A
(es)
|
2019-12-06 |
2022-07-11 |
Vertex Pharma |
Tetrahidrofuranos sustituidos como moduladores de canales de sodio.
|
|
CN117794920A
(zh)
|
2021-06-04 |
2024-03-29 |
沃泰克斯药物股份有限公司 |
N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂
|
|
LU102863B1
(en)
|
2021-10-19 |
2023-04-20 |
Kemijski Inst |
Small molecule-inhibitors of 6-phosphofructo-1-kinase for reducing Reactive oxygen species (ROS) generation by cancer cells
|